Exact Therapeutics AS (EXTX) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.697x

Based on the latest financial reports, Exact Therapeutics AS (EXTX) has a cash flow conversion efficiency ratio of -0.697x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-80.55 Million ≈ $-8.48 Million USD) by net assets (Nkr115.55 Million ≈ $12.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Exact Therapeutics AS PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Exact Therapeutics AS - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Exact Therapeutics AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. See EXTX net asset value for net asset value and shareholders' equity analysis.

Exact Therapeutics AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Exact Therapeutics AS ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fastator AB ST:FASTAT	0.055x
Perpetual Resources Ltd AU:PEC	-0.164x
European Electric Metals Inc V:EVX	-0.631x
Tinybeans Group Ltd AU:TNY	-0.191x
Uma Exports Limited NSE:UMAEXPORTS	0.041x
Asuransi Kresna Mitra Tbk PT JK:ASMI	-0.047x
USWE Sports AB ST:USWE	-0.007x
AMD Industries Limited NSE:AMDIND	0.104x

Annual Cash Flow Conversion Efficiency for Exact Therapeutics AS (2017–2024)

The table below shows the annual cash flow conversion efficiency of Exact Therapeutics AS from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see EXTX market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Nkr115.55 Million ≈ $12.16 Million	Nkr-80.55 Million ≈ $-8.48 Million	-0.697x	+29.02%
2023-12-31	Nkr45.10 Million ≈ $4.75 Million	Nkr-44.30 Million ≈ $-4.66 Million	-0.982x	-88.90%
2022-12-31	Nkr65.11 Million ≈ $6.85 Million	Nkr-33.85 Million ≈ $-3.56 Million	-0.520x	+0.24%
2021-12-31	Nkr105.74 Million ≈ $11.13 Million	Nkr-55.11 Million ≈ $-5.80 Million	-0.521x	-220.16%
2020-12-31	Nkr159.65 Million ≈ $16.80 Million	Nkr-25.99 Million ≈ $-2.73 Million	-0.163x	+44.84%
2019-12-31	Nkr42.24 Million ≈ $4.44 Million	Nkr-12.46 Million ≈ $-1.31 Million	-0.295x	-35.10%
2018-12-31	Nkr57.06 Million ≈ $6.00 Million	Nkr-12.46 Million ≈ $-1.31 Million	-0.218x	+85.37%
2017-12-31	Nkr8.35 Million ≈ $878.27K	Nkr-12.46 Million ≈ $-1.31 Million	-1.493x	--

About Exact Therapeutics AS

OL:EXTX Norway Biotechnology

Market Cap

$9.45 Million

Nkr89.83 Million NOK

Market Cap Rank

#27168 Global

#251 in Norway

Share Price

Nkr1.42

Change (1 day)

-2.07%

52-Week Range

Nkr1.27 - Nkr3.00

All Time High

Nkr40.90